General Information
DRAVP ID DRAVPe01603
Peptide Name RSG-P2G4
Sequence RPRGRRGSRPSGAERRRRRAAAA
Sequence Length 23
UniProt ID None
Source Synthetic construct
Activity Information
Target Organism HIV
Assay MAGI assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Not found
Mechanism Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe01603
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C102H187N53O28
Absent amino acids CDFHIKLMNQTVWY
Common amino acids R
Mass 2603.95
Pl 12.6
Basic residues 10
Acidic residues 1
Hydrophobic residues 5
Net charge 9
Boman Index -15094
Hydrophobicity -197.83
Aliphatic Index 21.74
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 5
Literature Information
Literature 1
Title Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
Pubmed ID 20580677
Reference Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.
Author Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.